Alzheimer’s disease hurts the quality of life of many of our beloved abuelos and abuelas, their family members, and caregivers. Fortunately, clinical trials can help us fight back against Alzheimer’s. You or your loved ones can volunteer for the REACH Clinical Trial that aims to slow the effects of Alzheimer’s disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. REACH Clinical Trial volunteers will be reimbursed up to $100 for each trial visit. “Our mission is to provide a compassionate and comprehensive network of clinical care for patients and their families with access to the most advanced treatment in clinical trials, as we continue to lead the search for a cure for Alzheimer’s and ...
Latinos spend $7,167 a year caring for aging loved ones, says an AARP survey. While this is actually less than what Whites caregivers spend out of pocket a year ($7,300), the financial strain is greater because it represents almost half the income of Latino caregivers, according to the report. Currently, over 48 million Americans provide unpaid care to an adult family member or friend who has a physical health condition or a mental health issue like Alzheimer's and dementia. Most caregivers say they use their own money to look after their loved ones, like rent or mortgage payments, home modifications like wheelchair ramps, and medical costs. "About half of caregivers say they have experienced financial setbacks. This may mean they have had to curtail their spending, dip into ...
We know Latinos are 1.5 times more likely to develop Alzheimer’s disease and dementia than whites. Now a new study shows that Latinos experience slightly different signs and symptoms of dementia, with more depression and anxiety and a faster rate of functional decline than Blacks or non-Hispanic Whites, AARP reports. Anxiety and depression are risk factors for dementia. Studies have suggested anxiety and depression can cause early manifestations of abnormal protein accumulations in the brain — amyloid and tau — which lead to dementia. In the new study of 5,000 people, researchers found more anxiety among Latinos (25.6 %) than Blacks (16.3 %) or Whites (11.3 %). "We need to do a better job of making mental health services accessible for these groups, with culturally ...
The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with Latinos being 1.5 times more likely to develop it than white people. “What's really exciting is that aducanumab is the first new FDA-approved Alzheimer's treatment in nearly 20 years, and we're optimistic this will spark a wave of new research and innovation in this space. Patients are excited for that, too, and if aducanumab is the first step toward that brighter future, patients are eager to be part of it,” said Dr. Rany Aburashed, ...
Latinos with cancer face a tough survivorship journey. Many suffer advanced disease, poor quality of life, and stressful social and economic inequities. This is why a new, first-of-its-kind national cohort study will unpack the social, cultural, behavioral, psychosocial, biological, and medical influences on post-cancer life in Latino cancer survivors to fill a crucial gap in knowledge about their survivorship experience. The study, “Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Study,” is funded by a 6-year, $9.8-million grant from the National Cancer Institute that will team up two of its Cancer Centers, the Mays Cancer Center, home to UT Health San Antonio MD Anderson and the Sylvester Comprehensive Cancer Center at the University of ...
Daniel Carlos Hughes thought he wanted to be a chemical engineer. He worked at Dow Chemical for 23 years, moving up to a middle management position. But then he had a midlife crisis. Now he works as a kinesiologist focuses on sport and exercise psychology. He researches holistic interventions for cancer prevention and with an emphasis on exercise and stress in Latina breast cancer survivors as a faculty member of the Institute for Health Promotion Research (IHPR) at UT Health San Antonio. While the career switch was risky and required many years of schooling, Hughes is glad to have found a calling where he can help cancer survivors live longer, fitter, better lives.
Hughes, a First Generation Mexican American in His Second Career
Hughes was born in Mexico City. His family ...
Cancer affects different people differently. For Latinos, the cancer survivorship journey is shaped by cultural and spiritual beliefs. Latinos also face struggles with barriers to care, screening, clinical trial participation, and patient-doctor communication. This is the focus of a new Spanish-language Facebook Live event, “Supervivencia: Viviendo a través y más allá del cáncer," set for 6-7:30 p.m. CST Monday, May 19, 2021. The Leukemia and Lymphoma Society (LLS) South Texas Chapter is sponsoring the event. Salud America! at UT Health San Antonio will host the event on its Facebook page. Register here for the Facebook Live event. The event will feature: Dr. José Cruz, MD, is a hematology and oncology expert with the Methodist Healthcare's Adult Blood and Marrow ...
In clinical trials, researchers test life-saving treatments and find ways to prevent and manage disease. But Latinos don't often participate in research. They account for less than 10% of people in federal cancer clinical trials. This makes it hard for researchers to create treatments that work best for Latinos. This is the focus of a new webinar, “Addressing Clinical Trial Enrollment Barriers in Unique Populations,” set for 1 p.m. ET Wednesday, April 21, 2021. The event is sponsored by Fight Colorectal Cancer. Register for the webinar. Panelists are: Amelie G. Ramirez, DrPh, is Director of the Salud America! program and its new project to engage more Latinos in cancer and Alzheimer's research (supported by a grant from Genentech, a member of the Roche Group), ...
Do you know fewer than 5% of Latinos participate in federal clinical trials? There is a historical lack of targeted research about Latino health inequities and how to address them, and a lack of diversity in clinical trials. Researchers thus have less chance to develop new treatments for this population, which suffers a heavy burden of certain cancers, dementia, obesity, and mental health issues. That's why we're excited to use #SaludTues on April 6, 2021, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, to mark National Minority Health Month in April. WHAT: Tweetchat: “Latino Participation Is Vital in Clinical Trials"
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, April 6, 2021
WHERE: On Twitter with hashtag ...
